Global PTCA Balloon Catheter Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter and Scoring Balloon Catheter.

By Delivery Platform;

Rapid Exchange (RX) / Monorail Balloon Catheter, and Over-the-wire (OTW) Balloon Catheter.

By Compliance;

Semi-Compliant, and Non-Compliant.

By Balloon Material;

Polyolefin copolymer (POC), Polyethylene (PE), and Polyethylene terephthalate (PET).

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn199149370 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global PTCA Balloon Catheter Market (USD Million), 2021 - 2031

In the year 2024, the Global PTCA Balloon Catheter Market was valued at USD 1,275.39 million. The size of this market is expected to increase to USD 1,708.84 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.3%.

The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is experiencing significant growth driven by the rising prevalence of cardiovascular diseases, technological advancements in catheter design, and increasing adoption of minimally invasive procedures. PTCA balloon catheters are commonly used in the treatment of coronary artery disease to dilate narrowed or blocked arteries and restore blood flow to the heart muscle. With the growing burden of cardiovascular diseases worldwide, there is a rising demand for interventional cardiology procedures, including PTCA, fueling market expansion.

Technological advancements in PTCA balloon catheters, such as the development of drug-coated balloons (DCBs) and scoring balloon catheters, are driving market growth by offering enhanced treatment outcomes and reducing the risk of restenosis. DCBs are designed to deliver antiproliferative drugs directly to the arterial wall, preventing the re-narrowing of arteries following angioplasty. Similarly, scoring balloon catheters incorporate specialized scoring elements to create controlled micro-incisions in calcified or fibrotic lesions, facilitating better balloon expansion and improving procedural success rates. These innovations in catheter design are revolutionizing the field of interventional cardiology, leading to improved patient outcomes and expanding the scope of PTCA procedures.

Moreover, the increasing adoption of minimally invasive techniques and the shift towards outpatient settings for cardiac interventions are driving market growth for PTCA balloon catheters. Minimally invasive procedures offer several advantages over traditional open surgeries, including shorter recovery times, reduced hospital stays, and lower complication rates. PTCA balloon catheters play a crucial role in minimally invasive interventions by enabling precise angioplasty procedures without the need for surgical incisions. Additionally, advancements in catheter technologies, such as improved navigational capabilities and enhanced visualization systems, are further enhancing the safety and efficacy of PTCA procedures, driving market expansion in the global interventional cardiology market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Delivery Platform
    3. Market Snapshot, By Compliance
    4. Market Snapshot, By Balloon Material
    5. Market Snapshot, By Region
  4. Global PTCA Balloon Catheter Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Cardiovascular Diseases
        2. Technological Advancements in Catheter Design
        3. Increasing Adoption of Minimally Invasive Procedures
      2. Restraints
        1. High Cost of Catheterization Procedures
        2. Risk of Complications such as Restenosis
        3. Regulatory Hurdles in Device Approval
      3. Opportunities
        1. Expansion of Emerging Markets
        2. Development of Drug-Coated Balloons
        3. Shift towards Outpatient Settings
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global PTCA Balloon Catheter Market, By Product Type, 2021 - 2031 (USD Million)
      1. Normal Balloon Catheter
      2. Drug Eluting Balloon Catheter
      3. Cutting Balloon Catheter
      4. Scoring Balloon Catheter
    2. Global PTCA Balloon Catheter Market, By Delivery Platform, 2021 - 2031 (USD Million)
      1. Rapid Exchange (RX) / Monorail Balloon Catheter
      2. Over-the-wire (OTW) Balloon Catheter
    3. Global PTCA Balloon Catheter Market, By Compliance, 2021 - 2031 (USD Million)
      1. Semi-Compliant
      2. Non-Compliant
    4. Global PTCA Balloon Catheter Market, By Balloon Material, 2021 - 2031 (USD Million)
      1. Polyolefin copolymer (POC)
      2. Polyethylene (PE)
      3. Polyethylene terephthalate (PET)
    5. Global PTCA Balloon Catheter Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic plc
      2. Abbott Laboratories
      3. Boston Scientific Corporation
      4. Terumo Corporation
      5. B. Braun Melsungen AG
      6. Cook Medical LLC
      7. Cordis Corporation (a Cardinal Health company)
      8. C. R. Bard, Inc. (acquired by Becton, Dickinson and Company)
      9. Biotronik SE & Co. KG
      10. Stryker Corporation
  7. Analyst Views
  8. Future Outlook of the Market